Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic…

Overview of attention for article published in PharmacoEconomics, September 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,102 followers.

RT @HealthEconBot: #HealthEconJA Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Pept…

04 Sep 2019

Reply Repost Favourite

#HealthEconJA Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review https://t.co/bge1VP7Wti

04 Sep 2019

Reply Repost Favourite